Advanced Biomed Inc. ADVB
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 242.16% | -- | 44.85% | 44.85% | 49.30% |
| Total Depreciation and Amortization | -578.49% | -- | -25.47% | 170.59% | -402.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | 100.00% | -270.26% |
| Change in Net Operating Assets | -272.31% | -- | 70.06% | -109.06% | 170.28% |
| Cash from Operations | -143.24% | -- | 60.47% | 60.47% | 54.72% |
| Capital Expenditure | 1,323.08% | -- | 91.04% | -115.65% | 622.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -191,446.15% | -- | 91.04% | 91.04% | -813.64% |
| Total Debt Issued | 40,630.43% | -- | 153.85% | 193.82% | -290.09% |
| Total Debt Repaid | -- | -- | 98.66% | -1,033.33% | 9.09% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -541.78% |
| Cash from Financing | 249.16% | -- | 158.46% | 158.46% | -112.98% |
| Foreign Exchange rate Adjustments | -195.89% | -- | -267.41% | -267.41% | 24.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -111,055.00% | -- | 89.15% | 89.15% | -190.24% |